shortagewatch

Home / Digestive tract and metabolism / Insulin Lispro

ATC A10AB04 · Insulins and Analogues for Injection, Fast-Acting

Insulin Lispro shortage

As of 2 Nov 2026, Insulin Lispro has a reported shortage in 3 of the 15 countries we track (United States, Canada, Norway), covering 6 products from 2 companies.

Countries3/15
Products6packs or presentations
Companies22 listed
Short since1 Sep 202514 months ago
Earliest return31 Dec 2026company estimate
Main reasonNot stated
United States2 products shortCanada1 product shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorway3 products shortSwedenNo reported shortageJapanNo reported shortageAustraliaNo reported shortage

Timeline

United StatesCanadaNorway
202620272028Humalog Mix 75/25, Injection, 100 [iU]/1 mL Humalog Mix 75/25, Injection, 100 [iU]/1 mL (NDC 0002-8233-05)Insulin Lispro Junior KwikPen, Injection, 10Insulin Lispro Junior KwikPen, Injection, 100 [iU]/1 mL (NDC 0002-7752-05)ADMELOG SOLOSTAR (5 cartridges/box)ADMELOG SOLOSTAR (5 cartridges/box)Insulin lispro Sanofi 100 E/ml injeksjonsvæsInsulin lispro Sanofi 100 E/ml injeksjonsvæske, oppløsning, 10 ml hetteglassInsulin lispro Sanofi 100 E/ml injeksjonsvæsInsulin lispro Sanofi 100 E/ml injeksjonsvæske, oppløsning i sylinderampulle, 5x3 ml sylinderampulleInsulin lispro Sanofi 100 E/ml injeksjonsvæsInsulin lispro Sanofi 100 E/ml injeksjonsvæske, oppløsning i ferdigfylt penn, 5x3 ml ferdigfylt penntoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Sanofi4 SANEli Lilly2 LLY

Listed: Eli Lilly LLY · NYSE, Sanofi SAN · Euronext Paris

Compared with similar medicines

ATC group A10AB · Insulins and Analogues for Injection, Fast-Acting
Insulin Aspart6/15Insulin Lispro3/15

Affected products

CountryProductCompanySinceExpected backReason
USHumalog Mix 75/25, Injection, 100 [iU]/1 mL (NDC 0002-8233-05) discontinuationEli Lilly and Co.1 Sep 2026not givenNot stated
USInsulin Lispro Junior KwikPen, Injection, 100 [iU]/1 mL (NDC 0002-7752-05) discontinuationEli Lilly and Co.1 Sep 2026not givenNot stated
CAADMELOG SOLOSTAR (5 cartridges/box)SANOFI-AVENTIS CANADA INC14 Aug 2026not givenOther
Other (Please describe in comments)
NOInsulin lispro Sanofi 100 E/ml injeksjonsvæske, oppløsning, 10 ml hetteglassSanofi Winthrop Industrie1 Sep 202531 Dec 2026Manufacturing problem
Produksjonsproblemer
NOInsulin lispro Sanofi 100 E/ml injeksjonsvæske, oppløsning i sylinderampulle, 5x3 ml sylinderampulleSanofi Winthrop Industrie31 Oct 202531 Dec 2026Manufacturing problem
Produksjonsproblemer
NOInsulin lispro Sanofi 100 E/ml injeksjonsvæske, oppløsning i ferdigfylt penn, 5x3 ml ferdigfylt pennSanofi Winthrop Industrie4 Mar 20261 Nov 2027Increased demand
Uventet økt etterspørsel (delvis mangel)

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.